+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Superdisintegrants Market by Type, Formulation, Therapeutic Area - Global Forecast 2025-2030- Product Image
Superdisintegrants Market by Type, Formulation, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Superdisintegrants Market by Type, Formulation, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336394
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Superdisintegrants Market grew from USD 567.93 million in 2023 to USD 629.44 million in 2024. It is expected to continue growing at a CAGR of 10.92%, reaching USD 1.17 billion by 2030.

Superdisintegrants are crucial excipients used in the pharmaceutical industry to facilitate the breakdown of tablets and capsules, ensuring quick dissolution and absorption of active ingredients in the body. Their necessity arises from the demand for efficient drug delivery systems that improve patient compliance and therapeutic effectiveness. Primarily employed in oral drug formulations, superdisintegrants are integral in applications ranging from over-the-counter pain relievers to prescription medications. The end-use scope is vast, encompassing pharmaceutical companies, contract production organizations, and supplement manufacturers.

The market for superdisintegrants is shaped by several growth factors, including the rising global demand for generic medicines, advancements in drug formulation technologies, and an increasing prevalence of chronic diseases. This trend is further supported by the expansion of the pharmaceutical industry in emerging markets. Opportunities abound, particularly in the development of novel superdisintegrants that improve drug release profiles and patient experiences, such as plant-based and sustainable options. Businesses could gain leverage by investing in research partnerships and focusing on the customization of superdisintegrants to meet specific therapeutic needs.

However, the market faces challenges such as stringent regulatory requirements which complicate the approval processes, and pricing pressures which can hinder profitability, especially in cost-sensitive markets. The variability in raw material quality poses an additional limitation, potentially affecting the performance consistency of superdisintegrants.

Innovation areas with high potential include the exploration of nanotechnology to enhance disintegration efficiency and bioavailability, and the development of multifunctional excipients that can reduce formulation complexities and production costs. Research focused on the impact of superdisintegrants on drug solubility and stability will yield valuable insights for market expansion.

Overall, the superdisintegrants market is dynamic and competitive, driven by continual advancements in drug delivery systems. By overcoming regulatory and cost challenges through innovative research and strategic partnerships, companies can capitalize on emerging opportunities in this growing segment.

Understanding Market Dynamics in the Superdisintegrants Market

The Superdisintegrants Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing consumption of orally disintegrating tablets and capsules
    • Rising adoption of the generic drugs
  • Market Restraints
    • Concerns related to the safety and quality of product
  • Market Opportunities
    • Development of new superdisintegrants for the pharmaceutical industry
    • Acceptance of natural superdisintegrants
  • Market Challenges
    • High-cost associated with manufacturing of superdisintegrants

Exploring Porter’s Five Forces for the Superdisintegrants Market

Porter’s Five Forces framework further strengthens the insights of the Superdisintegrants Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Superdisintegrants Market

External macro-environmental factors deeply influence the performance of the Superdisintegrants Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Superdisintegrants Market

The Superdisintegrants Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Superdisintegrants Market

The Superdisintegrants Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Superdisintegrants Market

The Superdisintegrants Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Superdisintegrants Market, highlighting leading vendors and their innovative profiles. These include Anshul Life Sciences, Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Performance Materials, LLC, BASF SE, DFE Pharma GmbH & Co KG, DowDuPont Inc., FMC Corporation, Gangwal Chemicals Pvt. Ltd., Huber Corporation, JRS PHARMA GmbH + Co. KG, Nippon Soda Co., Ltd., NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD., Roquette Frères S.A., and Sigachi Industries Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Natural Superdisintegrants
      • Gums
      • Mucilage
      • Plantago Ovata Mucilage
    • Synthetic Superdisintegrants
      • Calcium Silicates
      • Crospovidone
      • Ion Exchange Resins
      • Modified Cellulose
        • Croscarmellose Sodium
        • Low-Substituted Hydroxypropyl Cellulose
      • Modified Starch
  • Formulation
    • Mouth-Dissolving Films
    • Tablets & Capsules
  • Therapeutic Area
    • Cardiovascular Diseases
    • Gastrointestinal Diseases
    • Hematological Diseases
    • Infectious Diseases
    • Inflammatory Diseases
    • Neurological Diseases
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing consumption of orally disintegrating tablets and capsules
5.1.1.2. Rising adoption of the generic drugs
5.1.2. Restraints
5.1.2.1. Concerns related to the safety and quality of product
5.1.3. Opportunities
5.1.3.1. Development of new superdisintegrants for the pharmaceutical industry
5.1.3.2. Acceptance of natural superdisintegrants
5.1.4. Challenges
5.1.4.1. High-cost associated with manufacturing of superdisintegrants
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Superdisintegrants Market, by Type
6.1. Introduction
6.2. Natural Superdisintegrants
6.2.1. Gums
6.2.2. Mucilage
6.2.3. Plantago Ovata Mucilage
6.3. Synthetic Superdisintegrants
6.3.1. Calcium Silicates
6.3.2. Crospovidone
6.3.3. Ion Exchange Resins
6.3.4. Modified Cellulose
6.3.4.1. Croscarmellose Sodium
6.3.4.2. Low-Substituted Hydroxypropyl Cellulose
6.3.5. Modified Starch
7. Superdisintegrants Market, by Formulation
7.1. Introduction
7.2. Mouth-Dissolving Films
7.3. Tablets & Capsules
8. Superdisintegrants Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Gastrointestinal Diseases
8.4. Hematological Diseases
8.5. Infectious Diseases
8.6. Inflammatory Diseases
8.7. Neurological Diseases
8.8. Oncology
9. Americas Superdisintegrants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Superdisintegrants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Superdisintegrants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SUPERDISINTEGRANTS MARKET RESEARCH PROCESS
FIGURE 2. SUPERDISINTEGRANTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SUPERDISINTEGRANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SUPERDISINTEGRANTS MARKET DYNAMICS
TABLE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GUMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PLANTAGO OVATA MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CALCIUM SILICATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSPOVIDONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ION EXCHANGE RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MOUTH-DISSOLVING FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY HEMATOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 55. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 57. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 59. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 85. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 87. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 88. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 89. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 93. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 94. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 95. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 103. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 106. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 139. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 142. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 144. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 161. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 170. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 173. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 182. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 194. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 196. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 197. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 198. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 212. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 215. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 218. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 220. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 221. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 222. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 224. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 226. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 227. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 228. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 248. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 266. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 269. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 284. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 285. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Superdisintegrants Market, which are profiled in this report, include:
  • Anshul Life Sciences
  • Asahi Kasei Corporation
  • Ashland Global Specialty Chemicals Inc.
  • Avantor Performance Materials, LLC
  • BASF SE
  • DFE Pharma GmbH & Co KG
  • DowDuPont Inc.
  • FMC Corporation
  • Gangwal Chemicals Pvt. Ltd.
  • Huber Corporation
  • JRS PHARMA GmbH + Co. KG
  • Nippon Soda Co., Ltd.
  • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • Roquette Frères S.A.
  • Sigachi Industries Pvt Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 629.44 Million
Forecasted Market Value ( USD ) by 2030 $ 1170 Million
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2024-2032 - Product Image

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Superdisintegrants - Global Strategic Business Report - Product Image

Superdisintegrants - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Superdisintegrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Superdisintegrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
2024 Global Forecast for Superdisintegrants Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Superdisintegrants Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Superdisintegrant Market

Superdisintegrants are pharmaceutical intermediates used to facilitate the disintegration of tablets and capsules in the gastrointestinal tract. They are typically composed of polymers, starches, or cellulose derivatives, and are used to increase the rate of dissolution of the active pharmaceutical ingredient. Superdisintegrants are used in a variety of pharmaceutical formulations, including tablets, capsules, and granules. Superdisintegrants are used to improve the bioavailability of drugs, reduce the time to onset of action, and improve patient compliance. They are also used to reduce the size of tablets, improve the flowability of powders, and reduce the cost of production. Some of the companies in the Superdisintegrant market include BASF, Colorcon, Dow, Evonik, JRS Pharma, Roquette, and Wacker Chemie. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.